Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma

Acta Medica Okayama

Volumn 65, Issue 3, 2011, Pages 179-184

  Teramen, Hirotake ^a   Tsukuda, Kazunori ^a   Tanaka, Norimitsu ^a   Ueno, Tsuyoshi ^a   Kubo, Takafumi ^a   Ando, Midori ^a   Soh, Junichi ^a   Asano, Hiroaki ^a   Pass, Harvery I ^b   Toyooka, Shinichi ^a   Miyoshi, Shinichiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Lung cancer; Mesothelioma; Methylation; P21

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA;

AGED; ARTICLE; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; MALE; MESOTHELIOMA; METABOLISM; PHYSIOLOGY; PLEURA TUMOR;

AGED; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; RNA, MESSENGER;

EID: 79960143591     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inihibitor of G1 cyclin-dependent kinases. Cell (1993) 75: 805-816.
2. Garrel AL, Serfas MS and Tyner AL: p21-negative regulator of the cell cycle. Pros Soc Exp Biol Med (1996) 213: 138-149.
3. Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T, Sugio K, Brambilla E, Gilcrease M, Minna JD and Gazdar AF: DNA methy lation profiles of lung tumors. Mol Cancer Ther (2001) 1: 61-67.
4. Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, Gilcrease M, Farinas A, Minna JD and Gazdar AF: Aberrant methylation and simian virus 40 tag sequences in malig nant mesothelioma. Cancer Res (2001) 61: 5727-5730.
5. Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M and Fuchs CS: Down-regulation of p21(CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol (2006) 210: 147-154.
6. Ying J, Srivastava G, Gao Z, Zhang X, Murray P, Ambinder R and Tao Q: Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in vari ous lymphomas and carcinomas. Blood (2004) 103: 743-746.
7. Roman-Gomez J, Castillejo JA, Jimenez A, Gonzalez MG, Moreno F, Rodriguez Mdel C, Barrios M, Maldonado J and Torres A: 5'CpG island hypermethylation is associated with transcriptional silencing of the p21 (CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia. Blood (2002) 99: 2291-2296.
8. Fang JY and Lu YY: Effects of histone acetylation and DNA meth ylation on p21WAF1 regulation. World J Gastroenterol (2002) 8: 400-405.
9. ZhuWG, Srinivasan K, Dai Z Duan, W, Druhan LJ, DingH, Yee L, Villalona-Calero MA, Plass C and Otterson GA: Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the P21CIP1 promoter. Mol Cell Biol (2003) 23: 4056-4065.
10. Brakensiek K, Langer F, Kreipe H and Lehmann U: Absence of P21CIP1, p27KIP1 and p57KIP2 methylation in MDS and AML. LeukRes(2005)29: 1357-1360.
11. Baldi A, Groeger AM, Esposito V, Cassandra R, Tonini G, Battista T, Di Marino MP, Vincenzi B, Santini M, Angelini A, Rossiello R, Baldi F and Paggi MG: Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival. Thorax (2002) 57: 353-356.
12. Cheung CT, Hasan MK, Widodo N, Kaul SC and Wadhwa R: CARF: An emerging regulator of p53 tumor suppressor and senes cence pathway. Mech Ageing Dev (2009) 130: 18-23.
13. Dworakowska D, Jassem E, Jassem J, Boltze C, Wiedorn KH, Dworakowski R, Skokowski J, Jaskiewicz K and Czestochowska E: Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer. Acta Oncol (2005) 44: 75-79.
14. Kwon MS, Lee Yl and Lee KY: p21 as a prognostic factor in non-small cell lung carcinomas. Pathol Res Pract (2006) 202: 846-856.